Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
GEN Roundup: Multiplex Immunoassays Bring the Array, Not the Disarray
Get Multiplex Immunoassay Advice from GEN's Expert Panel
For full access to this article login to GEN Select now.
Makeover Mandated for U.K. Life Science Sector
Guidelines to Help the Industry Win Over Partners, Investors, and Public Opinion
- Experts at the government-backed body UK Trade and Investment (UKTI; www.uktradeinvest.gov.uk) believe that the U.K. biotech industry’s recent battering by high-profile financial press pundits not only temporarily dented its pride but also gave a very one-sided view of the true international potential of the country’s life science sector. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.